152
Views
3
CrossRef citations to date
0
Altmetric
Review

Epidemiology of Neuropathic Pain

&
Pages 87-96 | Published online: 22 Dec 2010

Bibliography

  • Porta M : A Dictionary of Epidemiology (5th Edition). Oxford University Press, New York, NY, USA (2008).
  • Merskey H , BogdukN: Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. IASP Press, Seattle, WA, USA (1994).
  • Loeser JD , TreedeRD: The Kyoto protocol of IASP basic pain terminology.Pain137(3) , 473–477 (2008).
  • Haanpaa ML , BackonjaMM, BennettMI et al.: Assessment of neuropathic pain in primary care.Am. J. Med.122(Suppl. 10) , S13–S21 (2009).
  • Haanpaa M , AttalN, BackonjaM et al.: International Association for the Study of Pain NeuPSIG guidelines on neuropathic pain assessment.Pain (2010) (Epub ahead of print).
  • Bennett MI , SmithBH, TorranceN et al.: Can pain be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians.Pain122(3) , 289–294 (2006).
  • Attal N , FermanianC, FermanianJ, Lanteri-MinetM, AlchaarH, BouhassiraD: Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?Pain138(2) , 343–353 (2008).
  • Crombie IK , CroftPR, LintonSJ, LeResche l, Von Korff M: Epidemiology of Pain (1st Edition). IASP Press, Seattle, WA, USA (1999).
  • Doth AH , HanssonPT, JensenMP et al.: The burden of neuropathic pain: a systematic review and meta-analysis of health utilities.Pain149(2) , 338–344 (2010).
  • Finnerup NB , OttoM, McQuayHJ, JensenTS, SindrupSH: Algorithm for neuropathic pain treatment: an evidence based proposal.Pain118(3) , 289–305 (2005).
  • Dworkin RH , O‘ConnorAB, BackonjaM et al.: Pharmacologic management of neuropathic pain: evidence-based recommendations.Pain132(3) , 237–251 (2007).
  • Attal N , CruccuG, BaronR et al.: EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Eur. J. Neurol.17(9) , 1113–e88 (2010).
  • Daniel HC , NarewskaJ, SerpellM et al.: Comparison of psychological and physical function in neuropathic pain and nociceptive pain: implications for cognitive behavioral pain management programs.Eur. J. Pain12(6) , 731–741 (2008).
  • Fields HL , RowbothamM, BaronR: Postherpetic neuralgia: irritable nociceptors and deafferentation.Neurobiol. Dis.5(4) , 209–227 (1998).
  • Baron R , TolleTR, GockelU et al.: A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms.Pain146(1–2) , 34–40 (2009).
  • Gremeau-Richard C , DubrayC, Aublet-CuvelierB et al.: Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial.Pain149(1) , 27–32 (2010).
  • Scholz J , WoolfCJ: Can we conquer pain?Nat. Neurosci. Suppl. 5 , 1062–1067 (2002).
  • Kieburtz K , SimpsonD, YiannoutsosC et al.: A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.Neurology51(6) , 1682–1688 (1998).
  • Shlay JC , ChalonerK, MaxMB et al.: Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.JAMA280(18) , 1590–1595 (1998).
  • Hahn K , ArendtG, BraunJS et al.: A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies.J. Neurol.251(10) , 1260–1266 (2004).
  • Abrams DI , JayCA, ShadeSB et al.: Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.Neurology68(7) , 515–521 (2007).
  • Ellis RJ , ToperoffW, VaidaF et al.: Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.Neuropsychopharmacology34(3) , 672–680 (2009).
  • Bennett GJ : Neuropathic pain: an overview. In: Molecular Biology of Pain. Borsook D (Ed.). IASP Press, Seattle, WA, USA, 109–113 (1997).
  • Bowsher D : Neurogenic pain syndromes and their management.Br. Med. Bul.47(3) , 644–666 (1991).
  • Dworkin RH : An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms.Clin. J. Pain18(6) , 343–349 (2002).
  • Wild S , RoglicG, GreenA et al.: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.Diabetes Care27(5) , 1047–1053 (2004).
  • Bowsher D : The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population.Eur. J. Pain3(4) , 335–342 (1999).
  • Davies M , BrophyS, WilliamsR et al.: The prevalence, severity, and impact of painful diabetic peripheral neuropathy in Type 2 diabetes.Diabetes Care29(7) , 1518–1522 (2006).
  • Choo PW , GalilK, DonahueJG et al.: Risk factors for postherpetic neuralgia.Arch. Intern. Med.157(11) , 1217–1224 (1997).
  • Freynhagen R , BaronR, GockelU et al.: painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.Curr. Med. Res. Opin.22(10) , 1911–1920 (2006).
  • Bennett MI , AttalN, BackonjaMM et al.: Using screening tools to identify neuropathic pain.Pain127(3) , 199–203 (2007).
  • Bennett MI , BouhassiraD: Epidemiology of neuropathic pain: can we use the screening tools?Pain132(1–2) , 12–13 (2007).
  • Torrance N , SmithBH, BennettMI et al.: The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.J. Pain7(4) , 281–289 (2006).
  • Bouhassira D , Lanteri-MinetM, AttalN et al.: Prevalence of chronic pain with neuropathic characteristics in the general population.Pain136(3) , 380–387 (2008).
  • Smith BH , TorranceN, BennettMI et al.: Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.Clin. J. Pain23(2) , 143–149 (2007).
  • Tesfaye S , ChaturvediN, EatonSE et al.: Vascular risk factors and diabetic neuropathy.N. Engl. J. Med.352(4) , 341–350 (2005).
  • Jensen TS , BackonjaMM, Hernandez Jimenez S et al.: New perspectives on the management of diabetic peripheral neuropathic pain. Diab. Vasc. Dis. Res.3(2) , 108–119 (2006).
  • Jung BF , JohnsonRW, GriffinDR et al.: Risk factors for postherpetic neuralgia in patients with herpes zoster.Neurology62(9) , 1545–1551 (2004).
  • Kehlet H , JensenTS, WoolfCJ: Persistent postsurgical pain: risk factors and prevention.Lancet367(9522) , 1618–1625 (2006).
  • Dieleman JP , KerklaanJ, HuygenFJ et al.: Incidence rates and treatment of neuropathic pain conditions in the general population.Pain137(3) , 681–688 (2008).
  • Gustorff B , DornerT, LikarR et al.: Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.Acta Anaesthesiol. Scand.52(1) , 132–136 (2008).
  • Toth C , LanderJ, WiebeS: The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population.Pain Med.10(5) , 918–929 (2009).
  • Yawn BP , SaddierP, WollanPC et al.: A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.Mayo Clin. Proc.82(11) , 1341–1349 (2007).
  • Opstelten W , MauritzJW, de Wit NJ et al.: Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam. Pract.19(5) , 471–475 (2002).
  • Helgason S , PeturssonG, GudmundssonS et al.: Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up.BMJ321(7264) , 794–796 (2000).
  • Younes M , BejiaI, AguirZ et al.: Prevalence and risk factors of disk-related sciatica in an urban population in Tunisia.Joint Bone Spine73(5) , 538–542 (2006).
  • Davies M , BrophyS, WilliamsR et al.: The prevalence, severity, and impact of painful diabetic peripheral neuropathy in Type 2 diabetes.Diabetes Care29(7) , 1518–1522 (2006).
  • Wu EQ , BortonJ, SaidG et al.: Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France.Curr. Med. Res. Opin.23(9) , 2035–2042 (2007).
  • Sjaastad O , PetersenHC, BakketeigLS: Supraorbital neuralgia. Vaga study of headache epidemiology.Cephalalgia25(4) , 296–304 (2005).
  • Hall GC , CarrollD, ParryD et al.: Epidemiology and treatment of neuropathic pain: the UK primary care perspective.Pain122(1–2) , 156–162 (2006).
  • Hall GC , CarrollD, McQuayHJ: Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002–2005.BMC Fam. Pract.9 , 26 (2008).
  • Sadosky A , McDermottAM, BrandenburgNA et al.: A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions.Pain Pract.8(1) , 45–56 (2008).
  • Taylor RS : Epidemiology of refractory neuropathic pain.Pain Pract.6(1) , 22–26 (2006).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.